'DOCTOR WHO' RETURNS TO SCI FI CHANNEL WITH A NEW SEASON, NEW COMPANION, AND EXCITING NEW ADVENTURES

David Tennant Returns to His Role as the Tenth Timelord, Joined by New Companion Martha Jones, Played by Freema Agyeman

New York, NY� April 23, 2007�SCI FI Channel and BBC Worldwide Americas today announced a major acquisition deal for the U.S. premiere of the third season of Doctor Who. The series will debut on SCI FI in July 2007, kicking off with the Doctor Who Christmas Special: The Runaway Bride, guest-starring award-winning comedy actress Catherine Tate.

In season three, David Tennant returns to his role as the mysterious, time-traveling Doctor. American audiences will meet the Doctor's brand-new sidekick, Martha Jones (Freema Agyeman), in the first official episode of the season, "Smith and Jones."

Chris Regina, Vice President of Programming, SCI FI Channel, said 'Doctor Who' has become a favorite among SCI FI audiences. We are happy to bring the show back for its third season and look forward to following the Doctor's continuing adventures with his newest companion."

Executive Producer and Lead Writer Russell T Davies says, "We were delighted and honored by the second series' success, and we can promise new thrills, new laughs and some terrifying new aliens. The Doctor and Martha are destined to meet William Shakespeare, blood-sucking alien Plasmavores, The Judoon � a clan of galactic stormtroopers � and a sinister Dalek plot in 1930s New York."

The deal, brokered by Lisa Hofer, Vice President of Co-Production & Sales, BBC Worldwide Americas, with the SCI FI Channel grants SCI FI the exclusive first-run rights for Season Three. The second season of the new Doctor Who earned impressive ratings during its airing on SCI FI, delivering an average of over one million viewers each week.

Candace Carlisle, COO, BBC Sales Company, commented, "SCI FI Channel has been a fantastic platform for the Doctor Who Series in the US. We're excited for the Season Three launch and think American audiences will simply love the Doctor's hip new companion."

BBC Video will continue to work with SCI FI Channel on joint marketing promotions to support the Doctor Who brand in the US.

Burton Cromer, Senior Vice President, Consumer Products, BBC Worldwide Americas said: "Our promotional partnership with the SCI FI Channel, both on-air and online, was a significant factor in the fantastic success we've had with the new Doctor Who. It's also helped drive awareness and sales of our 40 plus line of classic Doctor Who titles."

Doctor Who is produced by Phil Collinson. Executive Producers are Head of Drama, BBC Wales, Julie Gardner and Lead Writer Russell T Davies.

Doctor Who is a BBC production in association with CBC in Canada. It has also been sold to over 30 territories internationally, including Japan (NHK), Thailand (Channel 7), South Korea (KBS2), Australia (ABC), New Zealand (Prime), France (France 4), Spain and Portugal (People & Arts), Denmark (Danmarks Radio), Sweden (SVT), Holland (NOS, Channel 3), Italy (Canal Jimmy), Finland (YLE) and Norway (NRK).

About BBC Worldwide Americas:

BBC Worldwide Limited is the main commercial arm and a wholly owned subsidiary of the British Broadcasting Corporation (BBC). The company exists to maximise the value of the BBC's assets for the benefit of the licence payer and invest in public service programming in return for rights. The company has six core businesses: Global Channels, Global TV Sales, Magazines, Content & Production, Home Entertainment and Digital Media. In 2005/06 BBC Worldwide generated profits of 89 million pounds on sales of 784 million pounds.

About SCI FI:

SCI FI Channel is a television network where "what if" is what's on. SCI FI fuels the imagination of viewers with original series and events, blockbuster movies and classic science fiction and fantasy programming, as well as a dynamic Web site (www.scifi.com ) and magazine. Launched in 1992, and currently in 89 million homes, SCI FI Channel is a network of NBC Universal, one of the world's leading media and entertainment companies.